Justin Meiklem

Vancouver, British Columbia and Rehovot, Israel – October 29, 2026 — BioHarvest Sciences Inc. (“BioHarvest” or the “Company”), (NASDAQ: BHST) (TASE: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced that it will report its third quarter 2026 financial results before the market opening on Thursday, November 12,

Botanical Synthesis™-developed asset has now completed development, commercial-scale manufacturing and the applicable self-affirmed GRAS process and is ready for production at BioHarvest’s GMP facility. Milestone demonstrates BioHarvest’s ability to create proprietary plant-derived assets and advance them from plant-cell development through industrial manufacturing and commercialization. High-potency proprietary olive-derived Verbascoside composition demonstrates promising dose-dependent preclinical activity across

Progress demonstrates that BioHarvest’s Botanical Synthesis™ platform is capable of producing the targeted next-generation sweetening solution Vancouver, British Columbia and Rehovot, Israel – October 8, 2026 – Tate & Lyle PLC (Tate & Lyle), a global leader in ingredient solutions for healthier food and beverages, and BioHarvest Sciences Inc. (NASDAQ: BHST) (TASE: BHST) (BioHarvest), today

Vancouver  British Columbia and Rehovot, Israel – September 29, 2026 – BioHarvest Sciences Inc. (NASDAQ: BHST) (TASE: BHST) (FSE: 8MV0) (“BioHarvest” or the “Company”), a Botanical Synthesis company developing and manufacturing proprietary plant-based compositions for customers, partners and its own portfolio, announced today that its Board of Directors has authorized a share repurchase program, structured

Single-dose VINIA Daily Chews broaden demographics and usage occasions while demonstrating the commercial versatility of Botanical Synthesis Format expansion shows how BioHarvest can help CDMO partners move from plant-cell compositions to differentiated consumer products Vancouver, British Columbia and Rehovot, Israel – September 15, 2026 – BioHarvest Sciences Inc. (Nasdaq: BHST) (TASE: BHST) (FSE: 8MV0), a

Vancouver, British Columbia and Rehovot, Israel–(Newsfile Corp. – September 14, 2026) – BioHarvest Sciences Inc (Nasdaq: BHST) (TASE: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced that its Chief Executive Officer, Zaki Rakib, will present at the H.C. Wainwright 28th Annual Global Investment Conference, to be held September 14-16,